ABSTRACT. Reliable methodology for predicting the age of mature dogs is currently unavailable. In this study, amplicon sequencing of 50 blood samples obtained from diseased dogs was used to measure methylation in seven DNA regions. Significant correlations between methylation level and age were identified in four of the seven regions. These four regions were then tested in samples from 31 healthy toy poodles, and correlations were detected in two regions. The age of another 11 dogs was predicted using data from the diseased dogs and the healthy poodles. The mean difference between the actual and calculated ages was 34.3 and 23.1 months, respectively. Further research is needed to identify additional sites of age-related methylation and allow accurate age prediction in dogs.
doi: 10.1292/jvms. Research, Irvine, CA, U.S.A.) if necessary. Bisulfite treatment of DNA was performed using an EZ DNA Methylation-Gold Kit (Zymo Research) according to the manufacturer's instructions, and treated DNA was used as a template for PCR. The genomic region of interest was selected to analyze the methylation levels of CpG regions that correlated to the regions showing age-related methylation changes in humans [5, 6] . Briefly, approximately 1,000 bases flanking previously reported age-related methylation sites were retrieved from the human genome assembly hg38 using the UCSC genome browser (https://genome.ucsc.edu/cgi-bin/ hgGateway). Homologous regions in the canine genome were identified using the Basic Local Alignment Search Tool (BLAST) from the NCBI website (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Homologous DNA regions in the canine genome were identified for some, but not all, of the human age-related regions. In total, 11 genomic regions were identified for analysis in the canine genome. Oligonucleotide PCR primers were designed for bisulfite-treated DNA (converted DNA) using the Methprimer web tool (http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi) and were synthesized commercially (FASMAC, Atsugi, Japan). The nucleotide sequences of these primers, and their locations within the canine reference genome, are shown in Table 1 . Adapter nucleotides were added to the 5ʹ end of these PCR primers to provide primer binding sites for second-round PCR. First-round PCR was performed using the Epitaq HS PCR Kit (Takara, Kusatsu, Japan) according to the manufacturer's instructions. Second-round PCR was performed using the GoTaq Hot Start Colorless Master Mix (Promega, Madison, WI, U.S.A.) to add a nucleotide adapter for next-generation sequence analysis and nucleotide tags for individual discrimination from mixed samples. PCR products were electrophoresed and extracted from agarose gels, and then purified using the High Pure PCR Product Purification Kit (Roche Diagnostics, Mannheim, Germany).
We failed to amplify DNA fragments from four of the 11 regions. The PCR products from the seven successfully amplified genomic regions were submitted either for 250-or 300-bp pair-end Miseq analysis (Illumina, San Diego, CA, U.S.A.) at FASMAC Co., Ltd., depending on the length of the amplicon. Sequence data from Miseq analysis were processed and then aligned using U-gene software (Unipro, Novosibirsk, Russia) to find specific, highly methylated CpG sites. The numbers of changed (unmethylated) and unchanged (methylated) CpGs at each site were counted individually using a textedit word processor (Apple, Cupertino, CA, U.S.A.). Only regions with more than 200 sequences per individual were included for further analysis. The methylation rate was calculated as the number of unchanged CpGs divided by the sum of changed and unchanged CpGs for each site. Pearson's correlation coefficients were calculated to assess the correlation between each CpG site and the age of the dog. The CpG site with the highest correlation coefficient was selected for each DNA region (Table 2) . A scatter plot of the methylation rate at each CpG site against age, with a straight-line approximation, is shown in Fig.1 . There was a significant correlation between methylation levels and age at four of the seven CpG sites (P<0.05, Pearson's correlation coefficient). Neighboring CpG sites in the same DNA region with the four sites showed 90% (37/41 sites) agreement in their slope direction with age as reported in human cases [5] .
We then examined the methylation levels at the four CpG sites with significant correlations between age and methylation in clinically healthy dogs. Blood samples were obtained from 31 toy poodles at the Nishi Animal Hospital (Kagoshima, Japan) or at the Harada-gakuen Animal School (Kagoshima, Japan). Methylation levels were measured as described for the previous samples. There were significant correlations between methylation level and age at two of the four CpG sites that were analyzed (Fig.2) . We then attempted age prediction using another 11 client-owned dogs brought to Kagoshima University for veterinary care. Age was predicted by multiple regression analysis of the four CpG sites from the initial 50 client-owned dogs or the 2 CpG sites from the 31 healthy toy poodles ( Table 3 ). The mean absolute difference between actual and predicted age, calculated using multiple regression of data from four CpG sites, was 34.3 months. In five of the 11 dogs, the difference between actual and predicted age was less than 24 months. The mean absolute difference between actual and predicted age calculated using data from two CpG sites was 23.1 months. The difference between actual and predicted age was less than 24 months in seven of the 11 dogs. The maximum difference between actual and predicted age was observed in a 140 month-old dog whose predicted age based on methylation of two CpG sites was 70.8 months. Marked diremption was observed in some dogs. Factors (e.g. nutritional state, breed and disease) that influence methylation levels should be identified. Further exhaustive research, such as genome-wide methylation sequence analysis or development of a cost effective methylation array assay, may identify other, more accurate, age-related changes in the methylation of the canine genome. Consolidation of public databases of canine genome methylation may also help to identify other age-related methylation changes, as has been shown in humans [8] .
The biological relevance of some of the genes adjacent to the CpG sites that we studied has been reported, while the function of others, such as Genetic suppressor element 1 (GSE1), is largely unknown. Secretagogin (SCGN) is a calcium binding protein. A 
Fig. 1.
Scatter plots of age (months) and methylation rates of CpG sites with the highest correlation coefficients in seven DNA regions (A, C, F, H, I, J and K) in the canine genome. These seven regions were expected to show age-related methylation changes based on human studies [5, 6] . The name of the adjacent gene in the canine genome is given as the header label for each scatter plot. Straight-line approximations have been applied to each scatter plot, and Pearson's correlation coefficients are shown.
doi: 10.1292/jvms. negative correlation between SCGN mRNA expression in peripheral blood mononuclear cells and age has been reported [27] ; this age-related decrease in mRNA expression is possibly regulated by epigenetic changes. B-cell CLL/lymphoma 6 member B protein (BCL6B) is a transcription repressor and a potential tumor suppressor. Epigenetic silencing of BCL6B has been reported in human hepatocellular carcinoma [16] . Although expression of BCL6B by CD8 positive T cells has been reported [17] , its association with aging is unknown. Interestingly, the correlation between age and methylation observed in dogs at the BCL6B CpG site was the inverse of that found in humans [6] . The reason for this is unclear, and age-related BCL6B expression in dogs needs a further study. POU domain, class 4, transcription factor 2 (POU4F2) is a transcription factor, and hypermethylation of POU4F2 CpG sites has been reported in some tumors [22, 23] , but its biological relevance in aging has not been reported. Age-prediction by DNA methylation levels has been reported in humans using various tissue samples, including saliva, teeth and brain [2, 5, 10, 26] . However, blood sample are used in most studies, because they are easily obtained. The leukocyte subtype composition of the blood sample does not seem to affect the accuracy of the age prediction [10] . Thus, in this study, we examined methylation levels in dogs using peripheral blood samples. A major limitation of this study is the potential bias in the samples used in the first experiment, which were obtained mostly from sick dogs. Poor health status, especially in the case of age-related diseases, may cause methylation patterns that mimic age-related changes in methylation. A recent study in humans found that some age-related methylation changes become insignificant after restricting the study sample to those without history of major age-related diseases, such as diabetes mellitus, cardiovascular disease, stroke and cancer [6] . Our first experiment included dogs with age-related diseases, such as diabetes mellitus (n=4), cardiovascular disease (n=5) and tumors (n=12). Although the four age-related CpG sites identified in the first analysis were homologous to regions showing age-related changes in humans without age-related diseases [6] , the correlations between methylation and age in two of the four sites were not significant in our second experiment using only healthy toy poodles. Ideal age markers should be minimally affected by environmental or genetic factors.
In conclusion, we measured the methylation levels at selected CpG sites in dogs using next-generation amplicon sequencing and identified some age-related changes in methylation. Although age predictions made using the methylation levels at these CpG sites are not yet sufficiently accurate for practical use, further research to identify other age-related methylation sites may make accurate age prediction possible.
